Sign in

CIK 0001862150

  • Emerging growth company

Cingulate Inc.

Sign in to watch
Ticker
CING
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
863825535
Phone
+1 913-942-2300
Business address
1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
Former names
Cingulate Inc.

Securities

  • CING Common Stock Nasdaq
  • CINGW Warrants Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-16 Downey Bryan Wade EVP & Chief Commercial Officer Grant or award · Stock Option (right to Buy) +67,000 67,000
2026-07-16 Downey Bryan Wade EVP & Chief Commercial Officer Grant or award · Stock Option (right to Buy) +33,000 33,000
2025-11-03 Downey Bryan Wade Chief Commercial Officer Grant or award · Stock Option (right to Buy) +30,000 30,000

Page 1 of 1 · 3 trades